NRSN · Company research
NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History - Yahoo! Finance Canada | NeuroSense Therapeutics Ltd. (NRSN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| $1 bid-price compliance regained, but NeuroSense (Nasdaq: NRSN) still faces a listing deficiency. - Stock Titan | $1 bid-price compliance regained, but NeuroSense (Nasdaq: NRSN) still faces a listing deficiency. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| The $1 share-price rule is met, but NeuroSense still faces another Nasdaq listing test. - Stock Titan | The $1 share-price rule is met, but NeuroSense still faces another Nasdaq listing test. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| NeuroSense Regains Nasdaq Bid Price Compliance, Appeals Market Value Delisting Notice - The Globe and Mail | NeuroSense Regains Nasdaq Bid Price Compliance, Appeals Market Value Delisting Notice The Globe and Mail | View source ↗ | The Globe and Mail | Oct 3, 2026 | neutral | 0 | 0.6 |
| A $35 million Nasdaq market-value rule remains unmet; NeuroSense plans to seek more time. - Stock Titan | A $35 million Nasdaq market-value rule remains unmet; NeuroSense plans to seek more time. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| An experimental treatment for Lou Gehrig's disease was linked to a 65% lower risk of death. - Stock Titan | An experimental treatment for Lou Gehrig's disease was linked to a 65% lower risk of death. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| NeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq - The Globe and Mail | NeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq The Globe and Mail | View source ↗ | The Globe and Mail | Sep 10, 2026 | neutral | 0 | 0.6 |
| $NRSN stock is up 19% today. Here's what we see in our data. - Quiver Quantitative | $NRSN stock is up 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 4, 2026 | neutral | 0 | 0.6 |
| NeuroSense Therapeutics (NRSN) Slips 1.24% to $0.41, Hovering Near Key Support at $0.39 - Ascending Triangle - dars.gov.et | NeuroSense Therapeutics (NRSN) Slips 1.24% to $0.41, Hovering Near Key Support at $0.39 - Ascending Triangle dars.gov.et | View source ↗ | dars.gov.et | Sep 2, 2026 | neutral | 0 | 0.6 |
| One ALS drug plan replaces a single large trial with three focused studies - Stock Titan | One ALS drug plan replaces a single large trial with three focused studies Stock Titan | View source ↗ | Stock Titan | Aug 31, 2026 | neutral | 0 | 0.6 |
| NeuroSense Therapeutics Ltd. Revenue Breakdown – NASDAQ:NRSN - TradingView | NeuroSense Therapeutics Ltd. Revenue Breakdown – NASDAQ:NRSN TradingView | View source ↗ | TradingView | Aug 25, 2026 | neutral | 0 | 0.6 |
| $NRSN stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $NRSN stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 29, 2026 | neutral | 0 | 0.6 |
| NRSN Forecast — Price Target — Prediction for 2027 - TradingView | NRSN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Executive Officer of $NRSN Buys 250,000 Shares - Quiver Quantitative | Insider Purchase: Chief Executive Officer of $NRSN Buys 250,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 17, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 6, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.